Findings suggest developing HDAC6 inhibitors could be a novel new therapeutic avenue for the treatment of migraines.
Findings suggest developing HDAC6 inhibitors could be a novel new therapeutic avenue for the treatment of migraines.Findings suggest developing HDAC6 inhibitors could be a novel new therapeutic avenue for the treatment of migraines.